Tech Company Acquirers
Alexion Pharmaceuticals
Wondering who was acquired by Alexion Pharmaceuticals? Syntimmune, Enobia Pharma and Taligen Therapeutics were acquired by this biopharmaceutical company.
Company Overview
Company Name
Alexion Pharmaceuticals
Company Status
Publicly-held
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
121 Seaport Blvd.
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Alexion is a global biopharmaceutical company focused on developing life-transforming therapies for patients with devastating and rare disorders. Find company and career information.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/26/2018
Acquisitions By Alexion Pharmaceuticals
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ludwig Hantson
Chief Financial Officer
Paul Clancy
Executive Vice President
Indrani Franchini
Executive Vice President
Brian Goff
Vice President
Rana Strellis
VP - General Counsel
Ellen Chiniara
VP - Human Resources
Anne-Marie Law
VP - R & D
John Orloff
Browse more tech company acquirers:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs